drugset / Trial / NCT00116441
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of vaccination with autologous myeloma cells and an allogeneic granulocyte-macrophage colony stimulating factor (GM-CSF) producing cell line.
Timeline
- Start
- 2000-10
- Primary completion
- —
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Therapeutic Cellular Vaccine, GM-CSF Producing | Vaccine | — | — |